Marcus Unterrainer

5.0k total citations
137 papers, 2.1k citations indexed

About

Marcus Unterrainer is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Marcus Unterrainer has authored 137 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Radiology, Nuclear Medicine and Imaging, 44 papers in Pulmonary and Respiratory Medicine and 39 papers in Genetics. Recurrent topics in Marcus Unterrainer's work include Glioma Diagnosis and Treatment (39 papers), Medical Imaging Techniques and Applications (34 papers) and Radiomics and Machine Learning in Medical Imaging (26 papers). Marcus Unterrainer is often cited by papers focused on Glioma Diagnosis and Treatment (39 papers), Medical Imaging Techniques and Applications (34 papers) and Radiomics and Machine Learning in Medical Imaging (26 papers). Marcus Unterrainer collaborates with scholars based in Germany, United States and Switzerland. Marcus Unterrainer's co-authors include Peter Bartenstein, Nathalie L. Albert, Vera Wenter, Matthias Brendel, Harun Ilhan, Claus Belka, Bogdana Suchorska, Maximilian Niyazi, Andrei Todica and Jörg‐Christian Tonn and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and NeuroImage.

In The Last Decade

Marcus Unterrainer

130 papers receiving 2.1k citations

Peers

Marcus Unterrainer
Marcus Unterrainer
Citations per year, relative to Marcus Unterrainer Marcus Unterrainer (= 1×) peers Julia Furtner

Countries citing papers authored by Marcus Unterrainer

Since Specialization
Citations

This map shows the geographic impact of Marcus Unterrainer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Unterrainer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Unterrainer more than expected).

Fields of papers citing papers by Marcus Unterrainer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus Unterrainer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Unterrainer. The network helps show where Marcus Unterrainer may publish in the future.

Co-authorship network of co-authors of Marcus Unterrainer

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus Unterrainer. A scholar is included among the top collaborators of Marcus Unterrainer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus Unterrainer. Marcus Unterrainer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Holzgreve, Adrien, Mathias J. Zacherl, Maximilian Scheifele, et al.. (2025). [99mTc]Tc-antigranulocyte scintigraphy for prediction of bone marrow reserve prior to radioligand therapy in patients with metastatic castration resistant prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 52(12). 4446–4455. 1 indexed citations
3.
Holzgreve, Adrien, Marcus Unterrainer, Hans Peter Schmid, et al.. (2025). Changes of Prostate-Specific Membrane Antigen-Radioligand Uptake on PET with Systemic Therapy in Patients with Metastatic Renal Cell Carcinoma. Cancers. 17(11). 1736–1736.
4.
Unterrainer, Lena M., Adrien Holzgreve, Johannes Toms, et al.. (2025). 68Ga-FAPI and 18F-FAPI PET/CT for detection of nodal metastases prior radical cystectomy in high-risk urothelial carcinoma patients. European Journal of Nuclear Medicine and Molecular Imaging. 52(11). 3963–3974.
5.
Manapov, Farkhad, Adrien Holzgreve, Moritz Rabe, et al.. (2025). Advances of PET/CT in Target Delineation of Lung Cancer Before Radiation Therapy. Seminars in Nuclear Medicine. 55(2). 190–201.
6.
Schmidt-Hegemann, Nina-Sophie, Thilo Westhofen, Jens Ricke, et al.. (2024). Cost-effectiveness analysis of additional local prostate radio therapy in metastatic prostate cancer from a medicare perspective. Radiation Oncology. 19(1). 167–167. 1 indexed citations
7.
Trapp, Christian, Nina-Sophie Schmidt-Hegemann, Alexander Büchner, et al.. (2024). PSMA-PET/CT response after metastasis-directed radiotherapy of bone oligometastases in prostate cancer. PubMed. 8(1). 25–25. 2 indexed citations
8.
Wenter, Vera, Johannes Toms, Simon Lindner, et al.. (2024). PET/CT imaging of differentiated and medullary thyroid carcinoma using the novel SSTR-targeting peptide [18F]SiTATE – first clinical experiences. European Journal of Nuclear Medicine and Molecular Imaging. 52(3). 900–912. 5 indexed citations
9.
Weller, Jonathan, Marcus Unterrainer, Adrien Holzgreve, et al.. (2024). Patterns of intersectional tumor volumes in T2-weighted MRI and [18F]FET PET in adult glioma: a prospective, observational study. Scientific Reports. 14(1). 23071–23071. 1 indexed citations
10.
Holzgreve, Adrien, Hans Roland Dürr, Axel Stäbler, et al.. (2023). Finger Pain as an Uncommon Primary Manifestation of Lung Carcinoma. Diagnostics. 13(5). 901–901.
12.
Dekervel, Jeroen, Marcus Unterrainer, Eric Van Cutsem, et al.. (2023). 18F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical Use. Journal of Nuclear Medicine. 64(6). 835–841. 24 indexed citations
13.
Unterrainer, Lena M., Simon Lindner, Lennert Eismann, et al.. (2022). Feasibility of [68Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 49(10). 3571–3580. 28 indexed citations
14.
Ilhan, Harun, Markus Kroenke, Alexander Wurzer, et al.. (2022). 18F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Curative-Intent Radiation Therapy: A Bicentric Retrospective Study. Journal of Nuclear Medicine. 63(8). 1208–1214. 4 indexed citations
15.
Quach, Stefanie, Adrien Holzgreve, Louisa von Baumgarten, et al.. (2022). Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation?. European Journal of Nuclear Medicine and Molecular Imaging. 49(12). 4282–4283. 1 indexed citations
16.
Unterrainer, Marcus, Viktoria Ruf, Bogdana Suchorska, et al.. (2021). TERT-Promoter Mutational Status in Glioblastoma – Is There an Association With Amino Acid Uptake on Dynamic 18F-FET PET?. Frontiers in Oncology. 11. 645316–645316. 4 indexed citations
17.
Vettermann, Franziska, Marcus Unterrainer, Viktoria Ruf, et al.. (2020). Dual PET Imaging of an H3K27M-Mutant Glioma With 18F-GE-180 and 18F-FET PET. Clinical Nuclear Medicine. 45(12). 992–993. 4 indexed citations
18.
Wenter, Vera, Marcus Unterrainer, Sebastian Lehner, et al.. (2019). Long-term outcome of rare oncocytic papillary (Hürthle cell) thyroid carcinoma following (adjuvant) initial radioiodine therapy. European Journal of Nuclear Medicine and Molecular Imaging. 46(12). 2526–2535. 13 indexed citations
19.
Beyer, Leonie, Philipp M. Kazmierczak, Michael Ewers, et al.. (2019). Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's disease. NeuroImage Clinical. 24. 101949–101949. 10 indexed citations
20.
Unterrainer, Marcus, I. Winkelmann, Bogdana Suchorska, et al.. (2018). Biological tumour volumes of gliomas in early and standard 20–40 min 18F-FET PET images differ according to IDH mutation status. European Journal of Nuclear Medicine and Molecular Imaging. 45(7). 1242–1249. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026